Assignee
AMYLIN PHARMACEUTICALS INC
US108 patents
Top patents by PatentIndex Score
US7741269B2Jun 22, 2010
Exendins and exendin agonists for weight reduction and obesity
AMYLIN PHARMACEUTICALS INC88 citations99
US7297761B2Nov 20, 2007
Pharmaceutical compositions containing exendins
AMYLIN PHARMACEUTICALS INC114 citations99
US7153825B2Dec 26, 2006
Methods for glucagon suppression using modified exendins
AMYLIN PHARMACEUTICALS INC111 citations99
US7138375B2Nov 21, 2006
Use of exendins and agonists thereof for lowering plasma lipid
AMYLIN PHARMACEUTICALS INC95 citations99
US7115569B2Oct 3, 2006
Exendins, exendin agonists, and methods for their use
AMYLIN PHARMACEUTICALS INC114 citations99
US6989366B2Jan 24, 2006
Exendins, exendin agonists, and methods for their use
AMYLIN PHARMACEUTICALS INC111 citations99
US6956026B2Oct 18, 2005
Use of exendins for the reduction of food intake
AMYLIN PHARMACEUTICALS INC194 citations99
US6924264B1Aug 2, 2005
Modified exendins and exendin agonists
AMYLIN PHARMACEUTICALS INC169 citations99
US6872700B1Mar 29, 2005
Methods for glucagon suppression
AMYLIN PHARMACEUTICALS INC184 citations99
US6858576B1Feb 22, 2005
Methods for regulating gastrointestinal motility
AMYLIN PHARMACEUTICALS INC211 citations99
US8026210B2Sep 27, 2011
Exendins and exendin agonist analogs to regulate gastrointestinal motility
AMYLIN PHARMACEUTICALS INC43 citations98
US7691963B2Apr 6, 2010
Exendins and exendin agonists modified with polyamino acids
AMYLIN PHARMACEUTICALS INC48 citations98
US7521423B2Apr 21, 2009
Exendin pharmaceutical compositions
AMYLIN PHARMACEUTICALS INC96 citations98
US6902744B1Jun 7, 2005
Exendin agonist formulations and methods of administration thereof
AMYLIN PHARMACEUTICALS INC180 citations98
US6087334AJul 11, 2000
Anti-diabetic peptides
AMYLIN PHARMACEUTICALS INC118 citations98
US5686411ANov 11, 1997
Amylin agonist peptides and uses therefor
AMYLIN PHARMACEUTICALS INC148 citations98
US5234906AAug 10, 1993
Hyperglycemic compositions
AMYLIN PHARMACEUTICALS INC125 citations98
US7928065B2Apr 19, 2011
Methods of treatment using exendin peptides or GLP-1 peptides
AMYLIN PHARMACEUTICALS INC63 citations97
US7157555B1Jan 2, 2007
Exendin agonist compounds
AMYLIN PHARMACEUTICALS INC132 citations97
US6706689B2Mar 16, 2004
Treatment of acute coronary syndrome with GLP-1
AMYLIN PHARMACEUTICALS INC142 citations97
US6703359B1Mar 9, 2004
Inotropic and diuretic effects of exendin and GLP-1
AMYLIN PHARMACEUTICALS INC160 citations97
US7858740B2Dec 28, 2010
Exendin agonist compounds
AMYLIN PHARMACEUTICALS INC39 citations96
US7700549B2Apr 20, 2010
Exendin agonist analogs to treat diabetes
AMYLIN PHARMACEUTICALS INC43 citations96
US7683030B2Mar 23, 2010
Methods of treating diabetes with albumin-conjugated exendin peptides
AMYLIN PHARMACEUTICALS INC42 citations96
US7608692B2Oct 27, 2009
Exendins and exendin agonists modified with albumin
AMYLIN PHARMACEUTICALS INC43 citations96
US7442680B2Oct 28, 2008
Inotropic and diuretic effects of GLP-1 and GLP-1 agonists
AMYLIN PHARMACEUTICALS INC66 citations96
US7419952B2Sep 2, 2008
Use of exendins and agonists thereof to treat diabetes
AMYLIN PHARMACEUTICALS INC53 citations96
US7407932B2Aug 5, 2008
Methods for glucagon suppression using modified exendins
AMYLIN PHARMACEUTICALS INC41 citations96
US7223725B1May 29, 2007
Exendin agonist compounds
AMYLIN PHARMACEUTICALS INC83 citations96
US7105490B2Sep 12, 2006
Methods and compositions for treating polycystic ovary syndrome
AMYLIN PHARMACEUTICALS INC35 citations96
US6982248B2Jan 3, 2006
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
AMYLIN PHARMACEUTICALS INC78 citations96
US6894024B2May 17, 2005
Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide
AMYLIN PHARMACEUTICALS INC91 citations96
US6723530B1Apr 20, 2004
Polynucleotides encoding proexendin, and methods and uses thereof
AMYLIN PHARMACEUTICALS INC52 citations96
US6506724B1Jan 14, 2003
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
AMYLIN PHARMACEUTICALS INC177 citations96
US6114304ASep 5, 2000
Methods for regulating gastrointestinal motility
AMYLIN PHARMACEUTICALS INC103 citations96
US5175145ADec 29, 1992
Treatment of diabetes mellitus with amylin agonists
AMYLIN PHARMACEUTICALS INC55 citations96
US5124314AJun 23, 1992
Pharmaceutical compositions containing amylin
AMYLIN PHARMACEUTICALS INC83 citations96
US7105489B2Sep 12, 2006
Methods and compositions for treating polycystic ovary syndrome
AMYLIN PHARMACEUTICALS INC52 citations95
US7056887B2Jun 6, 2006
Treatment of acute coronary syndrome with GLP-1
AMYLIN PHARMACEUTICALS INC59 citations95
US5795861AAug 18, 1998
Methods for regulating gastrointestinal motility
AMYLIN PHARMACEUTICALS INC33 citations95
US5321008AJun 14, 1994
Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
AMYLIN PHARMACEUTICALS INC43 citations95
US5264372ANov 23, 1993
Receptor-based screening methods for amylin agonists and antagonists
AMYLIN PHARMACEUTICALS INC91 citations95
US7220721B1May 22, 2007
Exendin agonist peptides
AMYLIN PHARMACEUTICALS INC92 citations94
US6410511B2Jun 25, 2002
Formulations for amylin agonist peptides
AMYLIN PHARMACEUTICALS INC115 citations94
US5942227AAug 24, 1999
Pharmaceutical compositions containing antibodies to amylin
AMYLIN PHARMACEUTICALS INC33 citations94
US5281581AJan 25, 1994
Treatment of insulin resistance
AMYLIN PHARMACEUTICALS INC49 citations94
US5266561ANov 30, 1993
Treatment of type 2 diabetes mellitus
AMYLIN PHARMACEUTICALS INC71 citations94
US7696161B2Apr 13, 2010
Exendin agonist compounds
AMYLIN PHARMACEUTICALS INC43 citations93
US5677279AOct 14, 1997
Methods and compositions for treating pain with amylin or agonists thereof
AMYLIN PHARMACEUTICALS INC19 citations93
US5364841ANov 15, 1994
Treatment of obesity and essential hypertension and related disorders
AMYLIN PHARMACEUTICALS INC63 citations93
Showing the top 50 of 108 patents by PatentIndex Score.